GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Capex-to-Operating-Income

Prestige Consumer Healthcare (FRA:PBV) Capex-to-Operating-Income : 0.04 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Prestige Consumer Healthcare's Capital Expenditure for the three months ended in Mar. 2024 was €-2.89 Mil. Its Operating Income for the three months ended in Mar. 2024 was €75.58 Mil.

Hence, Prestige Consumer Healthcare's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.04.


Prestige Consumer Healthcare Capex-to-Operating-Income Historical Data

The historical data trend for Prestige Consumer Healthcare's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Capex-to-Operating-Income Chart

Prestige Consumer Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.07 0.03 0.02 0.03

Prestige Consumer Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.03 0.02 0.04

Competitive Comparison of Prestige Consumer Healthcare's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Capex-to-Operating-Income falls into.



Prestige Consumer Healthcare Capex-to-Operating-Income Calculation

Prestige Consumer Healthcare's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-8.786) / 315.035
=0.03

Prestige Consumer Healthcare's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-2.892) / 75.581
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prestige Consumer Healthcare  (FRA:PBV) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Prestige Consumer Healthcare Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Consumer Healthcare (FRA:PBV) Business Description

Traded in Other Exchanges
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines